Frankfurt - Delayed Quote EUR
ImmuPharma plc (25I.F)
0.0300
+0.0095
+(46.34%)
At close: May 7 at 10:57:43 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-1,364.4070
-1,364.4070
-2,347.0650
-4,833.1720
-3,329.4010
Investing Cash Flow
188.7620
188.7620
-77.4240
-50.2830
-569.2010
Financing Cash Flow
722.0960
722.0960
1,547.7300
702.0470
8,370.3540
End Cash Position
208.4810
208.4810
667.8130
1,649.3740
5,862.0570
Capital Expenditure
--
--
-106.0090
-50.9340
-360.2900
Issuance of Capital Stock
1,480.6830
1,480.6830
2,350.9090
3,550
8,000
Issuance of Debt
--
--
--
0
2,152.2520
Repayment of Debt
--
--
0
-722.9780
-836.6060
Free Cash Flow
-1,364.4070
-1,364.4070
-2,453.0740
-4,884.1060
-3,689.6910
12/31/2020 - 12/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade